An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients
NCT01707550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 414
Last updated 2016-11-02
Summary
This observational survey study will capture all renal transplant patients in Serbia who are currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive protocol.
Conditions
- Kidney Transplantation
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2011-01-31
- Completion
- 2011-01-31
Countries
- Serbia
Study Locations
More Related Trials
-
Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients
NCT02686619 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).
NCT01292226 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.
NCT02091414 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.
NCT00717314 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.
NCT00420472 ·Status: TERMINATED ·Phase: PHASE4
-
OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
NCT02005562 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
NCT00337493 ·Status: COMPLETED ·Phase: PHASE4
-
CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients
NCT00737659 ·Status: UNKNOWN ·Phase: PHASE4
-
Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation
NCT00943228 ·Status: COMPLETED ·Phase: PHASE4
-
PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
NCT00281619 ·Status: COMPLETED
-
A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
NCT00048152 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.
NCT00758602 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
NCT00446459 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients
NCT01014442 ·Status: COMPLETED ·Phase: PHASE3
-
Reasons for Mycophenolate Mofetil Dose Reduction and Impact on Graft Outcome in Renal Transplant Recipients
NCT01496703 ·Status: COMPLETED
-
A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
NCT00217152 ·Status: TERMINATED ·Phase: PHASE4
-
Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation
NCT00206076 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients
NCT00991510 ·Status: TERMINATED ·Phase: PHASE4
-
Myfortic vs. Cellcept in Kidney Transplant Recipients
NCT00533624 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107
NCT00149916 ·Status: COMPLETED ·Phase: PHASE3
-
Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients
NCT00121810 ·Status: COMPLETED ·Phase: PHASE4
-
Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients
NCT01375127 ·Status: COMPLETED
-
Pharmacokinetics of Mmf and Valganciclovir
NCT00189150 ·Status: COMPLETED ·Phase: PHASE4
-
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
NCT00118742 ·Status: COMPLETED ·Phase: PHASE4
-
Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
NCT00166244 ·Status: COMPLETED ·Phase: PHASE4